“Global Antibiotic Drugs market set to grow to $43.8bn by 2022” says Visiongain analyst
18 June 2018
Visiongain’ has launched a new pharma report Top 25 Antibiotic Drugs Manufacturers 2018: US, Europe, Japan, Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others
The development of antibacterial resistance has created an opportunity for the drug industry as new anti-infectives are constantly required to target resistant organisms. Currently, a major opportunity lies in the development of drugs required for the treatment of hospital acquired infections and are associated with increased mortality and morbidity. Hence, most of the pharmaceutical companies are recommended to develop combination products to broaden the antibacterial spectrum of activity for combating bacterial resistance.
The lead analyst of the report commented: “Asia-Pacific and RoW are the fastest growing regional markets in the global antibacterial drugs market. Therefore, companies looking to accelerate their overall growth are recommended to invest in these emerging economies and to exploit the untapped growth opportunities available there. Companies are recommended to invest in emerging nations such as India and China, to capitalize on the opportunities available in the form of unmet medical needs, rising disposable incomes of the consumers and increased exposure to improved healthcare facilities.”
Leading companies featured in the report include Pfizer Inc., Merck & Co., Novartis, GSK, Bayer AG, Allergan plc, Shionogi & Co., Ltd., Taisho Pharmaceutical Holdings, Daiichi Sankyo, Sun Pharmaceutical Industries
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033
The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033
31 May 2023
Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
26 May 2023
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033